Loading clinical trials...
Loading clinical trials...
This study is conducted in Africa and Asia. The aim of this study is to evaluate in the participating countries the orthopaedic status and the degree of arthropathy of severe haemophilia patients in g...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT06716814 · Haemophilia A (Moderate or Severe)
NCT06352216 · Haemophilia A, Synovitis, and more
NCT06831734 · Haemophilia A, Haemophilia B
NCT06285071 · Haemophilia A, Haemophilia B
NCT06752850 · Haemophilia A (Moderate or Severe), Hemophilia, Classic, and more
Novo Nordisk Investigational Site
Bangalore
Novo Nordisk Investigational Site
Casablanca
Novo Nordisk Investigational Site
Muscat
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions